Your browser doesn't support javascript.
loading
Inhibition of inositol kinase B controls acute and chronic graft-versus-host disease.
Thangavelu, Govindarajan; Du, Jing; Paz, Katelyn G; Loschi, Michael; Zaiken, Michael C; Flynn, Ryan; Taylor, Patricia A; Kirchmeier, Andrew Kemal; Panoskaltsis-Mortari, Angela; Luznik, Leo; MacDonald, Kelli P; Hill, Geoffrey R; Maillard, Ivan; Munn, David H; Serody, Jonathan S; Murphy, William J; Miklos, David; Cutler, Corey S; Koreth, John; Antin, Joseph H; Soiffer, Robert J; Ritz, Jerome; Dahlberg, Carol; Miller, Andrew T; Blazar, Bruce R.
Afiliación
  • Thangavelu G; Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
  • Du J; Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
  • Paz KG; Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
  • Loschi M; Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
  • Zaiken MC; Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
  • Flynn R; Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
  • Taylor PA; Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
  • Kirchmeier AK; Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
  • Panoskaltsis-Mortari A; Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
  • Luznik L; Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD.
  • MacDonald KP; Department of Immunology, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute and School of Medicine, University of Queensland, Brisbane, QLD, Australia.
  • Hill GR; Department of Immunology, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute and School of Medicine, University of Queensland, Brisbane, QLD, Australia.
  • Maillard I; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Munn DH; Georgia Cancer Center and.
  • Serody JS; Department of Pediatrics, Medical College of Georgia, Augusta University, Augusta, GA.
  • Murphy WJ; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.
  • Miklos D; Department of Dermatology and.
  • Cutler CS; Department of Internal Medicine, Laboratory of Cancer Immunology, University of California Davis Medical Center, Sacramento, CA.
  • Koreth J; Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA.
  • Antin JH; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.
  • Soiffer RJ; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.
  • Ritz J; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.
  • Dahlberg C; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.
  • Miller AT; Stem Cell/Bone Marrow Transplantation Program, Division of Hematologic Malignancy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.
  • Blazar BR; The Genomics Institute, Novartis Research Foundation (GNF), San Diego, CA.
Blood ; 135(1): 28-40, 2020 01 02.
Article en En | MEDLINE | ID: mdl-31697815
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Experimental / Tacrolimus / Fosfotransferasas (Aceptor de Grupo Alcohol) / Efecto Injerto vs Leucemia / Enfermedad Injerto contra Huésped Límite: Animals Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Experimental / Tacrolimus / Fosfotransferasas (Aceptor de Grupo Alcohol) / Efecto Injerto vs Leucemia / Enfermedad Injerto contra Huésped Límite: Animals Idioma: En Año: 2020 Tipo del documento: Article